Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy (Q38407322)

2 September 2017

title

Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy (English)

1 reference

2 September 2017

Craig A Press

1 reference

2 September 2017

Kelly G Knupp

series ordinal

1 reference

2 September 2017

Kevin E Chapman

series ordinal

1 reference

2 September 2017

publication date

3 April 2015

1 reference

2 September 2017

1 reference

2 September 2017

1 reference

2 September 2017

page(s)

49-52

1 reference

Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.02.043

Effects of cannabis on cognitive function in patients with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.02.043

Effects of cannabis on cognition in patients with MS: a psychometric and MRI study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.02.043

Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.02.043

Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.02.043

Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.02.043

Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.02.043

Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.02.043

Sleep-disordered breathing, behavior, and cognition in children before and after adenotonsillectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.02.043

Hypnotic and antiepileptic effects of cannabidiol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.02.043

Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.02.043

Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.02.043

Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2015.02.043

10.1016/J.YEBEH.2015.02.043

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference